GWM
BIO icon

Gilpin Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gilpin Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.31K Buy
+22
New +$7.68K 0.01% 370

Other funds holding BIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

Gilpin Wealth Management's BIO Position: Q3 2026 in Review

Gilpin Wealth Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 22 shares worth $8.31K. The stake represents 0.01% of the portfolio and ranks #370 among its holdings.

10 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Gilpin Wealth Management held 22 shares of Bio-Rad Laboratories Class A worth $8.31K as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Gilpin Wealth Management position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #370 holding.
  • 10 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.